作者：
Liu,J.F. [1]
;
Barry,W.T. [2]
;
Birrer,M. [3]
;
Lee,J.-M. [4]
;
Buckanovich,R.J. [5]
;
Fleming,G.F. [6]
;
Rimel,B.J. [7]
;
Buss,M.K. [8]
;
Nattam,S. [9]
;
Hurteau,J. [10]
;
Luo,W. [11]
;
Quy,P. [12]
;
Whalen,C. ;
Obermayer,L. ;
Lee,H. ;
Winer,E.P. ;
Kohn,E.C. ;
Ivy,S.P. ;
Matulonis,U.A.
作者单位：
Department of Medical Oncology, Massachusetts General HospitalBoston, MA, United States
[1]
Section of Hematology/Oncology, University of ChicagoChicago, IL, United States
[2]
Division of Gynecologic Oncology, North Shore University Health System, Evanston HospitalEvanston
[3]
Department of Biostatistics, Massachusetts General HospitalBoston, MA, United States
[4]
Department of Oncology, Fort Wayne Medical Oncology and HematologyFort Wayne, IN, United States
[5]
Cancer Therapy Evaluation Program, National Cancer InstituteBethesda, MD, United States
[6]
Women's Malignancies Branch, Center for Cancer Research, National Cancer InstituteBethesda, MD
[7]
Division of Hematology/Oncology, Beth-Israel Deaconess Medical CenterBoston, MA, United States
[8]
Department of Medical Oncology, Dana-Farber Cancer InstituteBoston, MA, United States
[9]
Department of Obstetrics and Gynecology, Cedars-Sinai Medical CenterLos Angeles, CA, United States
[10]
Department of Biostatistics and Computational Biology, Dana-Farber Cancer InstituteBoston, MA
[11]
Department of Medical Oncology, University of MichiganAnn Arbor, MI, United States
[12]
发布时间
2014-12-20
换一批
